25 February 2026 - Top Stories

AI and data are moving fast as Australian health systems confront growing demand. Across rich nations, primary care is under strain as ageing populations and multimorbidity rise while clinicians juggle more documentation. In Australia, the push is toward tech-enabled, team-based primary care that can deflect hospital pressure and strengthen chronic‑disease management, with funding reform and digital tools central to the plan.

Pharmx Technologies and Sigma Healthcare have signed a multi-year alliance to embed technology across Sigma’s Australian and New Zealand wholesale and chemist networks, with an upfront establishment fee of about A$8.7 million. The deal positions Pharmx as the core tech platform and aims to harmonise wholesale and retailer systems through data‑driven supply chains, potentially reshaping competition as integration deepens.

BP Premier has integrated Lyrebird Health’s AI scribe into its free tier, extending AI-assisted note taking to clinics that might not otherwise invest in automation. With roughly 85% of Australia’s GP market on BP Premier, the move could accelerate AI adoption, improve in-consult documentation, and push rivals to rethink pricing, interoperability and the breadth of AI-enabled workflows.

AI-driven disruption is denting the traditional moats of Australia’s health software players. Major platforms have seen sharp pullbacks in valuation even as revenue holds steady, reflecting a broader re-pricing of AI-enabled development. Pathology rebound is strengthening incentives for data sharing and AI use, while governance moves—like Magentus becoming the first signatory to the voluntary AI health code—set higher standards for validation and monitoring.

Rural and workforce angles remain front of mind: eight NT GP Scholarships, ranging from A$5,000 to A$20,000 per year, back incoming GPs in remote communities, with the largest funding directed to the Kanyini Scholarships for rural registrars. Separately, analysts warn that non-specialist doctors bear a higher health impairment risk, underscoring the need for workforce wellbeing analytics and risk-monitoring tools across Australia.

• Accelerate AI-enabled primary care workflows and team-based care to ease hospital demand
• Scale data-driven pharmacy supply chain integration with Pharmx-Sigma
• Adopt AI governance: join the AI health code, require validation and ongoing monitoring
• Leverage pathology data sharing and AI to boost productivity and GP network performance
• Invest in rural GP workforce through NT scholarships and telehealth-enabled training
• Develop workforce wellbeing analytics for non-specialist clinicians